106
Views
7
CrossRef citations to date
0
Altmetric
Original Research

ARID4B Knockdown Suppresses PI3K/AKT Signaling and Induces Apoptosis in Human Glioma Cells

, , , &
Pages 1843-1855 | Published online: 10 Mar 2021

References

  • Koul N, Sharma V, Dixit D, Ghosh S, and Sen E. Bicyclic triterpenoid Iripallidal induces apoptosis and inhibits Akt/mTOR pathway in glioma cells. BMC Cancer. 2010;10(328). doi:10.1186/1471-2407-10-328
  • Chu CW, Ko HJ, Chou CH, et al. Thioridazine Enhances P62-Mediated Autophagy and Apoptosis Through Wnt/β-Catenin Signaling Pathway in Glioma Cells. International Journal of Molecular Sciences. 2019;20(473). doi:10.3390/ijms20030473
  • Wang K, Ruan J, Qian Q, et al. BRCAA1 monoclonal antibody conjugated fluorescent magnetic nanoparticles for in vivo targeted magnetofluorescent imaging of gastric cancer. Journal of Nanobiotechnology. 2011;9(23). doi:10.1186/1477-3155-9-23
  • Wu RC, Zeng Y, Pan IW, and Wu MY. Androgen Receptor Coactivator ARID4B Is Required for the Function of Sertoli Cells in Spermatogenesis. Molecular Endocrinology. 2015;29(9):1334–1446. doi:10.1210/me.2015-1089
  • Wu MY, Eldin KW, and Beaudet AL. Identification of Chromatin Remodeling Genes Arid4a and Arid4b as Leukemia Suppressor Genes. Journal of the National Cancer Institute. 2008;100:1247–1259. doi:10.1093/jnci/djn253
  • Wu RC, Young IC, Chen YF, Chuang ST, Toubaji A, and Wu MY. Identification of the PTEN-ARID4B-PI3K pathway reveals the dependency on ARID4B by PTEN deficient prostate cancer. Nature Communication. 2019;10(4332). doi:10.1038/s41467-019-12184-8
  • Winter SF, Lukes L, Walker RC, Welch DR, Hunter and KW. Allelic Variation and Differential Expression of the mSIN3A Histone Deacetylase Complex Gene Arid4b Promote Mammary Tumor Growth and Metastasis. PLoS Genetics. 2012;8(5). doi:10.1371/journal.pgen.1002735
  • Tsai WC, Hueng DY, Nieh S, and Gao HW. ARID4B is a good biomarker to predict tumour behaviour and decide WHO grades in gliomas and meningiomas. Journal of Clinical Pathology. 2017;70:162–167. doi:10.1038/s41467-019-12184-8
  • Lee WH, Yeh MY, Tu YC, Han SH and Wang YC. Establishment and characterization of a malignant glioma cell line, GBM8401/TSGH, NDMC. Journal of Surgical Oncology. 1988;38(3):173–181. doi:10.1002/jso.2930380309
  • Sharma T, Schwalbe EC, Williamson D, et al. Second‑generation molecular subgrouping of medulloblastoma: an international meta‑analysis of Group 3 and Group 4 subtypes. Acta Neuropathologica. 2019;138(2):309–326. doi:10.1007/s00401-019-02020-0.
  • Kato S, Han SY, Liu W, et al. Understanding the function–structure and function–mutation relationships of p53 tumor suppressor protein by high-resolution missense mutation analysis. PANS. 2003;100(14):8424–8429. doi:10.1073/pnas.1431692100
  • Goldberger N, Walker RC, Kim CH, Winter S, and Hunter KW. Inherited variation in miR-290 expression suppresses breast cancer progression by targeting the metastasis susceptibility gene Arid4b. Cancer Research. 2013;73(8):11. doi:10.1158/0008-5472.CAN-12-3513
  • Chao L, Yang J, Can W, et al. BRCAA1 antibody- and Her2 antibody-conjugated amphiphilic polymer engineered CdSe/ZnS quantum dots for targeted imaging of gastric cancer. Nanoscale Research Letters. 2014;9(244). doi:10.1186/1556-276X-9-244
  • Daxiang C, Chunlei Zh, Bing L, et al. Regression of Gastric Cancer by Systemic Injection of RNA Nanoparticles Carrying both Ligand and siRNA. Scientific Reports. 2015;5(10726). doi:10.1186/1477-3155-9-23
  • Rongchang W, Zheng Y, Fan Ch, Chunlian L, Qian W and Xiaohui H. Overexpression of ARID4B predicts poor survival in patients with hepatocellular carcinoma. Human Pathology. 2018;73. doi:10.1016/j.humpath.2017.12.012..
  • Abraham AG and O’Neill E. PI3K/Akt-mediated regulation of p53 in cancer. Signalling and Acquired Resistance to Targeted Cancer Therapeutics. 2014;42:798–803. doi:10.1042/BST20140070
  • Xu WT, Yang Z, and Lu NG. A new role for the PI3K/Akt signaling pathway in the epithelial-mesenchymal transition. Cell Adhesion & Migration. 2015;9(4):317–324. doi:10.1080/19336918.2015.1016686
  • Liu YG, Zheng J, Zhang Y, et al. Fucoxanthin Activates Apoptosis via Inhibition of PI3K/Akt/mTOR Pathway and Suppresses Invasion and Migration by Restriction of p38-MMP-2/9 Pathway in Human Glioblastoma Cells. Neurochemical Research. 2016;41:2728–2751. doi:10.1007/s11064-016-1989-7
  • Raul AG, Hugo GR, Emmanuel ML, et al. SurvExpress: An Online Biomarker Validation Tool and Database for Cancer Gene Expression Data Using Survival Analysis. PLOS ONE. 2013;8(9). doi:10.1371/journal.pone.0074250
  • Roué G, Pichereau V, Lincet H, Colomer D, and Sola B. Cycling D1 mediates resistance to apoptosis through upregulation of molecular chaperones and consequent redistribution of cell death regulators. Oncogene. 2008;27:4909–4920. doi:10.1038/onc.2008.126
  • Seo SK, Jin HO, Woo SH, et al. Histone Deacetylase Inhibitors Sensitize Human Non-small Cell Lung Cancer Cells to Ionizing Radiation Through Acetyl p53-Mediated c-myc Down-Regulation. Journal of Thoracic Oncology. 2011;6:1313–1319. doi:10.1097/JTO.0b013e318220caff
  • Fre ´de ´ric LJ and Ueli SS. Combined HDAC1 and HDAC2 Depletion Promotes Retinal Ganglion Cell Survival After Injury Through Reduction of p53 Target Gene Expression. American Society for Neurochemistry. 2015;7(3). doi:10.1177/1759091415593066
  • Reed SM and Quelle DE. p53 Acetylation: Regulation and Consequences. p53 Acetylation: Regulation and Consequences. 2015;7:30–69. doi:10.3390/cancers7010030.
  • Zhang Y, Dube C, Gibert Jr.M, et al. The p53 Pathway in Glioblastoma. Cancers. 2018;10(297). doi:10.1073/pnas.1431692100.